"First in Man" Total Percutaneous Aortic Arch Repair With 3-Inner-branch Endografts: A Report of Two Cases.

医学 外科 主动脉弓 经皮 动脉瘤 解剖(医学) 主动脉夹层 支架 体外循环 主动脉瘤 放射科
作者
Justine Mougin,Ron Azogui,Julien Guihaire,Mark R Tyrrell,Gustavo S Oderich,Dominique Fabre,Stéphan Haulon
出处
期刊:Annals of Surgery [Lippincott Williams & Wilkins]
卷期号:274 (6): e652-e657
标识
DOI:10.1097/sla.0000000000005167
摘要

Aneurysms of the arch are a complex clinical problem and a technical challenge. Currently, over 40% of patients are considered unfit for conventional open surgery, requiring a cardiopulmonary bypass and hypothermic circulatory arrest. In experienced hands and appropriate anatomic conditions, arch-branched graft technology has shown to be a safe and effective alternative to open conventional surgery to patients that historically have had no surgical options.This report summarizes the first in man implant of a three-vessel arch branch stent graft using a total percutaneous approach without the need for exposure of the cervical arteries-a surgical step with inherent problems and risks.This approach was performed in two consecutive patients, a 66-year-old woman with a chronic post type A dissection 60 mm diameter aneurysm of the aortic arch, and a 72-year-old man with a 70 mm saccular degenerative atheromatous aortic arch aneurysm.Technical success was obtained in both cases. The patients were extubated in the operating theatre. Neither suffered any pre- or postoperative neurological deficits. Both were discharged home after remarkably uneventful hospital stays. There were no access complications. Postoperative computerized tomography scans and ultra-sound confirmed patent supra-aortic branches and completely excluded aneurysms.Our new truly minimally invasive approach demonstrates that it is possible to manage one of the most challenging treatments of aortic pathologies without any surgical incision. Further, evaluation and experience are required to confirm these promising results.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
Troy完成签到,获得积分10
刚刚
脑洞疼应助科研通管家采纳,获得10
刚刚
慕青应助未来可期采纳,获得10
刚刚
刚刚
zhonglv7应助科研通管家采纳,获得10
刚刚
Twonej应助科研通管家采纳,获得30
1秒前
英姑应助科研通管家采纳,获得10
1秒前
顾矜应助科研通管家采纳,获得10
1秒前
深情安青应助科研通管家采纳,获得10
1秒前
科研小农民完成签到,获得积分10
1秒前
zzrg完成签到,获得积分10
1秒前
1秒前
1秒前
天天快乐应助科研通管家采纳,获得10
1秒前
1秒前
fangy34完成签到,获得积分10
1秒前
1秒前
领导范儿应助社会好公民采纳,获得10
2秒前
坚强的蔷薇薇完成签到 ,获得积分10
2秒前
pluto应助我想毕业采纳,获得10
2秒前
科目三应助waaliyh采纳,获得10
3秒前
充电宝应助dwj采纳,获得10
3秒前
乐正追命发布了新的文献求助10
3秒前
Venus完成签到 ,获得积分10
3秒前
3秒前
4秒前
毛林永发布了新的文献求助10
4秒前
mmol发布了新的文献求助10
4秒前
pp完成签到,获得积分10
4秒前
zpp发布了新的文献求助10
4秒前
4秒前
程风破浪发布了新的文献求助10
4秒前
赫尔海发布了新的文献求助10
5秒前
lately完成签到,获得积分10
5秒前
蟹黄面给蟹黄面的求助进行了留言
5秒前
su完成签到,获得积分10
5秒前
6秒前
衡阳发布了新的文献求助10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Burger's Medicinal Chemistry, Drug Discovery and Development, Volumes 1 - 8, 8 Volume Set, 8th Edition 1800
Cronologia da história de Macau 1600
Contemporary Debates in Epistemology (3rd Edition) 1000
International Arbitration Law and Practice 1000
文献PREDICTION EQUATIONS FOR SHIPS' TURNING CIRCLES或期刊Transactions of the North East Coast Institution of Engineers and Shipbuilders第95卷 1000
BRITTLE FRACTURE IN WELDED SHIPS 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 计算机科学 化学工程 生物化学 物理 复合材料 内科学 催化作用 物理化学 光电子学 细胞生物学 基因 电极 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6159794
求助须知:如何正确求助?哪些是违规求助? 7987960
关于积分的说明 16602496
捐赠科研通 5268201
什么是DOI,文献DOI怎么找? 2810869
邀请新用户注册赠送积分活动 1791001
关于科研通互助平台的介绍 1658101